Study protocol for a randomized clinical pilot trial investigating feasibility and efficacy of augmenting a virtual reality-assisted intervention targeting auditory verbal hallucinations with biofeedback: The Neuro-VR study
Open Access
- 26 February 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (2) , e0333716
Abstract
Introduction: Auditory Verbal Hallucinations (AVH) are among the most frequent and severe symptoms in schizophrenia and related psychotic disorders. Virtual Reality (VR)-assisted interventions have emerged, demonstrating promising potential in reducing AVH severity. This treatment approach may be challenged with regards to feasibility, particularly when therapeutically managing the anxiety-related reactions associated with AVH. This pilot study evaluates the feasibility and acceptability of augmenting VR-assisted therapy with real-time biofeedback to address these challenges. The integration of biofeedback enables continuous adaptation of therapy based on physiological responses while allowing participants to train self-regulation of these parameters. Methods: Neuro-VR is a randomized clinical pilot trial utilizing a mixed-methods design. Thirty participants with schizophrenia spectrum disorders and AVH will be randomized to either eight sessions of VR-assisted therapy or eight sessions of VR-assisted therapy augmented with real-time biofeedback. Assessments will be conducted at baseline and post-treatment. Outcome measures include both clinical metrics, electroencephalogram recordings, and qualitative interviews to evaluate feasibility, acceptability, and potential treatment effects of the combined approach. Discussion: This study will explore whether integrating biofeedback into VR-assisted therapy enhances personalization, supports emotion regulation, and improves tolerability. The findings will provide preliminary evidence on the utility of physiological markers to guide VR-based interventions for AVH and inform the development of individualized, effective treatments for patients with schizophrenia. Trial registration: ClinicalTrials.gov NCT06628323 .Keywords
Funding Information
- Lundbeck Foundation (R436-2023-957)
This publication has 105 references indexed in Scilit:
- Heart rate variability: Origins, methods, and interpretive caveatsPsychophysiology, 1997
- The auditory hallucination: a phenomenological surveyPsychological Medicine, 1996
- The Omnipotence of Voices II: the Beliefs About Voices Questionnaire (BAVQ)The British Journal of Psychiatry, 1995
- Initial reliability and validity of a new retrospective measure of child abuse and neglectAmerican Journal of Psychiatry, 1994
- A self‐report Insight Scale for psychosis: reliability, validity and sensitivity to changeActa Psychiatrica Scandinavica, 1994
- The Social Functioning Scale the Development and Validation of a New Scale of Social Adjustment for use in Family Intervention Programmes with Schizophrenic PatientsThe British Journal of Psychiatry, 1990
- Positive and Negative Symptoms in SchizophreniaArchives of General Psychiatry, 1990
- The Pittsburgh sleep quality index: A new instrument for psychiatric practice and researchPsychiatry Research, 1989
- Assessment of client/patient satisfaction: Development of a general scaleEvaluation and Program Planning, 1979
- Biofeedback as therapy: Some theoretical and practical issues.American Psychologist, 1973